FindTrial
Sign In

Blood Product Transfusion during Modified Ultrafiltration in Low-body Weight Infants Undergoing Complex Cardiac Surgery with CPB

Blood Product Transfusion during Modified Ultrafiltration in Low-body Weight Infants Undergoing Complex Cardiac Surgery with CPB

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104220
Enrollment
Unknown
Registered
2025-06-12
Start date
2024-12-24
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

experimental group (Blood product transfusion during modified ultrafiltration):NA
control group (Blood product transfusion after modified ultrafiltration):NA

Sponsors

Children's Hospital affiliated to Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Children with complex congenital heart disease (CHD) . 2. Body weight <=5 kg. 3. Use of MUF after CPB. 4. Postoperative transfusion of blood products (e.g., platelets, plasma).

Exclusion criteria

Exclusion criteria: 1. Preoperative coagulation disorders. 2. Pre-existing major organ failure (e.g., renal, hepatic, or respiratory failure). 3. Use of anticoagulant medications preoperatively. 4. Patients requiring unplanned reoperation postoperatively. 5. Postoperative use of extracorporeal membrane oxygenation (ECMO) or mortality.

Design outcomes

Primary

MeasureTime frame
thoracic drainage;—

Secondary

MeasureTime frame
thrombelastography;tubation timeICU stay time, hospitalization time;postoperative blood product transfusion;—

Countries

China

Contacts

Public ContactCui Jie

Children’s Hospital of Chongqing Medical University

158186318@qq.com+86 185 8056 8317

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026